Ian Metzler, MD
Urology · Portland, ORNPI 1508200346
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Ethicon Endo-surgery Inc. at 34.9% of the total. Reporting peaked in 2022 at $14,315 and has fallen 87.4% since, to $1,801 in 2025. Among urology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $510.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ethicon Endo-surgery Inc.$8K
- Intuitive Surgical$5K
- Alnylam Pharmaceuticals Inc.$5K
- Johnson & Johnson$2K
- C. R. Bard, Inc. & Subsidiaries$1K
- Auris Health, Inc.$1K
- plus $1K from 7 others
What the payments were for
- Consulting fees$13,91259%
- Speaking & faculty fees$1,4006%
- Travel & lodging$2,49711%
- Food & beverage$1,6717%
- Education$4,00417%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ethicon Endo-surgery Inc. | 3 | $8,202 |
| Intuitive Surgical | 7 | $5,045 |
| Alnylam Pharmaceuticals Inc. | 1 | $4,640 |
| Johnson & Johnson | 10 | $1,686 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,400 |
| Auris Health, Inc. | 2 | $1,275 |
| Boston Scientific | 16 | $765 |
| Calyxo, Inc. | 1 | $267 |
| Coloplast | 1 | $75 |
| Neotract Inc. | 1 | $59 |
| Cook Medical LLC | 1 | $51 |
| Baxter Healthcare | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monarch Platform$9,308
- OXLUMO$4,640
- DA VINCI SP$4,000
- MONARCH$1,440
- Da Vinci Surgical System$914
- CVAC Aspiration System$267
- REZUM$122
- LithoVue$119
How this compares
$23,484 in reported general payments places this provider in the 90th percentile of 153 urology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 48 | $3,512 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $322 |
| Tamsulosin Hcl | 44 | $235 |
| Finasteride | 21 | $162 |
| Oxycodone Hcl | 21 | $49 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other urology in Portland
- Lance MarrPortland$323K
- da David JiangPortland$65K
- Amir PatelPortland$36K
- James TycastPortland$35K
- Sudhir IsharwalPortland$30K
- Sara Spettel AliyarPortland$21K
- Daniel JanoffPortland$15K
- James BreseePortland$14K
- Stanley MyersPortland$11K
- Sajal DuttaPortland$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.